A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
The FDA approval of a landmark pancreatic cancer drug costing $480,000 annually signals a shifting economic landscape for oncology treatments.
9 trends tracked about this subject — the full history, oldest to newest below.
The FDA approval of a landmark pancreatic cancer drug costing $480,000 annually signals a shifting economic landscape for oncology treatments.
Bungie is seeking to sublease portions of its massive Bellevue headquarters following a period of significant workforce reductions.
13 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Sports story right now — PULSE is tracking how fast it spreads.
1 news sources are covering this Sports story right now — PULSE is tracking how fast it spreads.
1 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.